Muscle Contraction: Too much of a good thing

A mutation that causes heart disease in humans increases the number of active myosin heads during contraction in the muscles of fruit flies, leading to the progressive dysfunction of the flight muscles and heart tube.
  1. H Lee Sweeney  Is a corresponding author
  1. University of Florida, United States

Our muscles help us to move, eat, breathe and pump blood through our body. The skeletal and heart muscles of vertebrates consist of bundles of muscle fibers, with each fiber containing thousands of smaller structures called myofibrils. Within these myofibrils, thick myosin filaments and thin actin filaments can slide past each other to change the length of the muscle. This involves a part of a myosin filament, called the myosin head, 'grabbing hold' of an actin filament.

Controlling the interactions between the myosin heads and actin is a finely tuned and highly regulated process, and even small changes to it can lead to dysfunction and disease. For example, in a condition called hypertrophic cardiomyopathy, mutations in the myosin head can cause the walls of the heart to thicken, ultimately restricting the outflow of blood (Garfinkel et al., 2018). So far, it has been unclear how the mutations can cause these problems. Now, in eLife, Sanford Bernstein, Douglas Swank and colleagues at San Diego State University, Rensselaer Polytechnic Institute and Johns Hopkins University – including William Kronert as first author – report the surprising finding that a mutation in the motor portion of the myosin head that causes human hypertrophic cardiomyopathy can lead to degeneration of the flight muscles as well as the dysfunction of the heart tube in fruit flies (Kronert et al., 2018).

What appears to underlie this seemingly perplexing result is a loss of proper interactions either within myosin heads or, possibly, between the myosin heads and other components of the myosin filament. These interactions normally lead to the myosin heads being packed onto the ‘backbone’ of the myosin filament in a way that restricts their interactions with the actin filaments.

The myosin head contains a motor domain, a regulatory light chain and an essential light chain. The key structural insights into the packing of the myosin heads came from studying the regulation of smooth muscle myosin in vertebrates, which is inactive unless the regulatory light chain is phosphorylated (Wendt et al., 2001). This work revealed asymmetric interactions (known as the 'interacting head motif’) between neighboring myosin heads, which trapped both heads in inactive conformations: the actin binding site of one head was blocked by binding to the other in a way that prevented the latter from releasing the products of ATP hydrolysis when it interacted with actin (Figure 1). Interacting head motifs have also been found in the skeletal muscle of tarantulas, the heart muscles of vertebrates, and even in primitive animals that do not form muscles (Alamo et al., 2016; Woodhead et al., 2005; Lee et al., 2018; Zoghbi et al., 2008).

An interacting head motif.

A schematic view of an interacting head motif: the motor domain of one myosin head (the blocked head, shown in purple) has its actin binding site blocked by interactions with the second head (the free head). The essential light chain (ELC) and regulatory light chain (RLC) of each myosin head are also involved in the formation of the interacting head motif.

In an energy conserving ‘super-relaxed state’, myosin is trapped in a state with very low basal ATPase activity (Stewart et al., 2010). This appears to be a mechanism to stabilize myosin in its ‘pre-powerstroke’ state, in which inorganic phosphate and ADP are confined within the myosin head. Kronert et al. suggest that this pre-powerstroke state is destabilized by the mutation they were studying.

The researchers used fruit flies with a specific mutation on the side of the myosin head, called K146N, which causes thickening of the heart wall in humans. In the flies, the mutation leads to a degenerated heart tube and flight muscles. For both humans and flies, the problem appears to be the same: too many myosin heads interact during contraction and attach to actin for longer than usual, leading to hyperactivation, damage and disorder in the muscle. Myosin was able to create more force, while the movement of actin slowed down. Over time, the increased cost of performing work caused the muscles to degenerate. Although this does not lead to hypertrophy of the flight muscles – as it does in the human heart – there is decreased relaxation and restriction of the heart tube in the flies, paralleling human hypertrophic cardiomyopathy.

The ‘myosin mesa’ theory hypothesizes that many of the mutations causing hypertrophic cardiomyopathy are surface mutations that interfere with the formation and/or stabilization of the interacting head motif (Trivedi et al., 2018). It also proposes that a subset of these mutations might lead to interactions with another protein of the thick filament of the heart muscle, the myosin-binding protein C, which could help stabilize the interactions between the two myosin heads in the interacting head motif. This in turn could explain why mutations in myosin-binding protein C can also cause hypertrophic cardiomyopathy. Based on these concepts, a drug that stabilizes the super-relaxed state and the interacting head motif is being developed for the treatment of human hypertrophic cardiomyopathy (Anderson et al., 2018).

All in all, fruit flies may be a surprisingly good model to test the effects of mutations associated with human hypertrophic cardiomyopathy, apart from those that may interact directly with myosin-binding protein C, which is not present in fruit flies. However, the major significance of the work is that it underscores that since the super-relaxed state and the packing of interacting head motifs onto thick filaments is conserved throughout the evolution of muscle, it is likely that their functions – which would be to control the number of myosin heads available to interact with actin when the muscle is activated, and to lower the energetic cost when the muscle is relaxed – are also conserved.

References

Article and author information

Author details

  1. H Lee Sweeney

    H Lee Sweeney is in the Myology Institute and the Department of Pharmacology and Therapeutics, University of Florida, Gainesville, United States

    For correspondence
    lsweeney@ufl.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6290-8853

Publication history

  1. Version of Record published: September 17, 2018 (version 1)

Copyright

© 2018, Sweeney

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,599
    views
  • 134
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. H Lee Sweeney
(2018)
Muscle Contraction: Too much of a good thing
eLife 7:e41178.
https://doi.org/10.7554/eLife.41178

Further reading

    1. Cancer Biology
    2. Cell Biology
    Alex Weiss, Cassandra D'Amata ... Madeline N Hayes
    Research Article

    High-throughput vertebrate animal model systems for the study of patient-specific biology and new therapeutic approaches for aggressive brain tumors are currently lacking, and new approaches are urgently needed. Therefore, to build a patient-relevant in vivo model of human glioblastoma, we expressed common oncogenic variants including activated human EGFRvIII and PI3KCAH1047R under the control of the radial glial-specific promoter her4.1 in syngeneic tp53 loss-of-function mutant zebrafish. Robust tumor formation was observed prior to 45 days of life, and tumors had a gene expression signature similar to human glioblastoma of the mesenchymal subtype, with a strong inflammatory component. Within early stage tumor lesions, and in an in vivo and endogenous tumor microenvironment, we visualized infiltration of phagocytic cells, as well as internalization of tumor cells by mpeg1.1:EGFP+ microglia/macrophages, suggesting negative regulatory pressure by pro-inflammatory cell types on tumor growth at early stages of glioblastoma initiation. Furthermore, CRISPR/Cas9-mediated gene targeting of master inflammatory transcription factors irf7 or irf8 led to increased tumor formation in the primary context, while suppression of phagocyte activity led to enhanced tumor cell engraftment following transplantation into otherwise immune-competent zebrafish hosts. Altogether, we developed a genetically relevant model of aggressive human glioblastoma and harnessed the unique advantages of zebrafish including live imaging, high-throughput genetic and chemical manipulations to highlight important tumor-suppressive roles for the innate immune system on glioblastoma initiation, with important future opportunities for therapeutic discovery and optimizations.

    1. Cancer Biology
    2. Cell Biology
    Ian Lorimer
    Insight

    Establishing a zebrafish model of a deadly type of brain tumor highlights the role of the immune system in the early stages of the disease.